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This study was performed to evaluate the total phenols, flavonoids, and antioxidant activities of twenty-four propolis samples from
different regions of Morocco. In addition, two samples were screened regarding the antibacterial effect against four Staphylococcus
aureus strains. Gas chromatography coupled to mass spectra (GC-MS) analysis was done for propolis samples used in antibacterial
tests. The minimum inhibitory and minimum bactericidal concentration (MIC, MBC) were determined. The potential to acquire
the resistance after sequential exposure of bacterial strains and the impact of adaptation to propolis on virulence using the Galleria
mellonellawere evaluated. Additionally, the effects of propolis extract on the bacterial adherence ability and its ability to inhibit the
quorum sensing activity were also examined. Among the twenty-four extracts studied, the samples from Sefrou, Outat el Haj, and
the two samples marketed in Morocco were the best for scavenging DPPH, ABTS, NO, peroxyl, and superoxide radicals as well as
in scavenging of hydrogen peroxide. A strong correlation was found between the amounts of phenols, flavonoids, and antioxidant
activities. Propolis extract at theMIC value (0.36mg/mL) significantly reduced (p< 0.001) the virulence potential of S. aureusATCC
6538 and the MRSA strains without leading to the development of resistance in the sequence of continuous exposure. It was able
to impair the bacterial biofilm formation. The results have revealed that sample 1 reduces violacein production in a concentration
dependent manner, indicating inhibition of quorum sensing. This extract has as main group of secondary metabolites flavonoids
(31.9%), diterpenes (21.5%), and phenolic acid esters (16.5%).
1. Introduction
Reactive oxygen species (ROS) have a dual role in living
beings. In adequate concentrations, they have a beneficial
effect because they may constitute as defense against infec-
tious agents, or being involved in some cellular signaling
systems. Nevertheless, at higher concentrations, they damage
cell structures (membranes) and biomolecules (lipids, nucleic
acids, and proteins), leading to the known oxidative stress and
consequently to the development of several age-dependent
diseases (cancer, arteriosclerosis, arthritis, and neurode-
generative diseases, among others) [1]. The above shows
that the organisms produce ROS, if not adequately con-
trolled, through antioxidant systems; they are responsible
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for deleterious effects in the body. Such antioxidant systems
may be endogenous [vitamin A, enzyme cofactors (Q10),
nitrogen compounds (uric acid), and peptides (glutathione),
enzymes (glutathione peroxidase, catalase, superoxide dis-
mutase, glutathione reductase, and glucose-6-phosphate
dehydrogenase)] or supplied through the diet (exogenous)
[2]. Compounds present in food with potential antioxidant
activity include vitamins C, E, and K, phenols (phenolic
acids, flavonoids, thymol, and carvacrol, among others),
and carotenoids [2, 3]. Thus, antioxidants, mainly those
originating fromnatural products, are of a high important for
the human health.
Elseways, Staphylococcus aureus (Gram positive bac-
terium) is both a human commensal and pathogen. This
bacterium mainly colonizes the anterior nares of the nose;
nevertheless the remaining part of the respiratory tract, as
well as the gastrointestinal tract, skin, perineum, vagina, and
axillae, may also be target of colonisation [4]. S. aureus is one
of the main causes of hospital-acquired infections, whenever
the patients are submitted to intravenous drugs or under
treatment with enteral feedings or dialysis, in postopera-
tive surgical wounds in decubitus ulcers or in indwelling
catheters, and almost always associated with a compromised
defence mechanism [5–8]. In addition to the nosocomial
infections, its incidence is increasing also in the community
[9]. Moreover, this bacterium has a noteworthy potential
to develop resistance to antibiotics. Methicillin resistant S.
aureus (MRSA), which are resistant to 𝛽-lactam class of
antibiotics (penicillins, cephalosporins, and carbapenems),
are causing severe nosocomial infections [8, 10].
Equally important to mention that, bacterial pathogenic
cells that adhere closely to an abiotic or biotic surface
are responsible for serious infections, because such biofilm
matrix and phenotypic characteristics of the bacteria confer
resistance to the action of antimicrobial agents. Furthermore,
such biofilm may develop either on living tissues or on
inert surfaces of medical devices, leading to infections in
urogenital, gastrointestinal, respiratory tracts and eyes, and
wounds generally difficult to treat [11, 12].
Besides, intercellular communication within biofilms has
been attributed to the quorum sensing system (QS) which
is mediated by diffusible small signalling molecules [12,
13]. Bacteria in biofilms are resistant to disinfectants and
antibiotics leading to persistent infections, due to their higher
virulence. To find compounds which are able to interfere with
the bacterial QS systemwill regulate the virulence of bacterial
pathogens, regardless of multidrug resistance [13].
Propolis, a natural resinous substance constituted by resin
(50%), wax (30%), essential oils (10%), pollen (5%), and other
substances (5%), such as debris, minerals, and organic com-
pounds, possess antimicrobial, anti-inflammatory, antioxi-
dant, antidiabetic, spasmolytic, anaesthetic, anticancer, and
immunomodulatory effects [14].
The antioxidant activity of propolis extracts and/or their
constituents has been deeply evaluated worldwide, including
in the Mediterranean basin: Algeria [15–17]; Croatia [18,
19]; Cyprus [20]; Egypt [21, 22]; Greece [20]; Italy [23–25];
Macedonia [26]; Serbia [27]; Slovenia [28]; Spain [29, 30];
andTurkey [31, 32], using severalmethodologies: antioxidant;
reducing power; chelating activity; capacity for scavenging
the DPPH,ABTS, peroxyl [oxygen radical absorbance capac-
ity (ORAC)] and NO free radicals; capacity for scavenging
the superoxide anion radical; and capacity for scavenging
hydrogen peroxide. Very few works on antioxidant activity
of Moroccan propolis were found [33, 34]. Otherwise, the
in vitro antimicrobial activity of propolis against S. aureus
and MRSA strains has been reported [15, 35–44]; however in
Moroccan propolis such information is scarce or even absent.
The aim of the present work was to evaluate propolis as a
natural product regarding the antioxidant activity, measured
through the capacity for scavenging diverse free radicals
(DPPH, ABTS, superoxide, NO, and peroxyl); capacity for
reducing ion metals or chelating activity of hydro-alcoholic
extracts of propolis was assessed, allowing to determine by
whichmechanisms they act as antioxidants, at the same time,
the in vitro antibacterial activity of hydro-alcoholic extracts
ofMoroccan propolis against S. aureus strains, mainly MRSA
clinical isolates, as well as the effect of the adaptation of the
S. aureus strains on the susceptibility to propolis extract, and
its influence on the adherence of those microorganisms to
surfaces. The capacity for preventing this adherence reveals
to be of particular interest because the adherent bacterial
cells (biofilm bacteria) are more resistant to antibiotics than
planktonic cells. In addition the ability of propolis extract to
inhibit the QS system, diminishing the virulence of bacterial
pathogens, was also screened.
2. Methods
2.1. Chemical. Iron (II) chloride anhydrous and 6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox)
were purchased from Fluka Chemicals (Buchs, Switzerland).
Thiobarbituric acid, ferulic acid, DNP (2,4-dinitrophenylhy-
drazine), quercetin, sulphuric acid (H
2
SO
4
), potassium hy-
droxide (KOH), ABTS (2,2’-azino bis(3thylbenzothiazoline-
6-sulphonic acid), fluorescein sodium salt, sodium nitrite
ASC reagent, and eryodictiol were purchased from Fluka
Biochemika, Sigma-Aldrich, Steinheim, Germany. Acetic
acid, potassium dihydrogen phosphate (KH
2
PO
4
), dipotas-
sium hydrogen phosphate (K
2
HPO
4
), and trichloroacetic
acid were purchased from VWR, Leuven, Belgium.
Phenazine methosulfate (PMS), nicotinamide adenine dinu-
cleotide disodium salt hydrate (NADH), ferrozine iron
reagent hydrate; AAPH [2,2’-Azobis (2-methylpro-
pionamidine) dihydrochloride]; ethylenediaminetetraacetic
acid (EDTA), and potassium persulfate were purchased from
Acros organics, New Jersey, USA. Nitrotetrazolium blue
chloride and trichloroacetic were purchased from Sigma
Aldrich Chemie, Steinheim, Germany. Phosphate buffered
saline tablets (PBS) were from Fisher Scientific, New Jersey,
USA. Sodium nitroprussiate dehydrate, 2,2’-diphenyl-1-
picrylhydrazyl (DPPH), and potassium hexacyanoferrate
were from Riedel-de Hae¨n, Sigma-Aldrich, Seelze, Germany.
Griess reagent system was purchased from Promega
Corporation, Madison, USA. Calcium chloride, Folin
Ciocalteu’s phenol reagent, AlCl
3
, di-potassium hydrogen
phosphate anhydrous (K
2
HPO
4
), and hydrogen peroxide
(H
2
O
2
) were purchased from Panreac Quimica, Montcada i
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Reixac, Barcelona, Spain. Potassium dihydrogen phosphate
(KH
2
PO
4
) andNa
2
CO
3
were purchased fromRiedel deHaen
(Seelze, Germany, Riedel-de-Hae¨n Laboratory Chemicals,
Germany). Potassium chloride (KCl) was purchased from
Analar Normapur, Geldenaaksebaan, Leuven, Belgium.
Ammonium heptamolybdate tetrahydrate PA was purchased
from PRONALAB, LISBOA, Portugal. The medium brain-
heart infusion (BHI), Luria-Bertani (LB), and bacteriological
agar type E were purchased from Biokar Diagnostics
(Beauvais, France). Crystal violet was fromMerck, Germany.
2.2. Propolis Extraction. Hydro-alcoholic extracts of twenty-
four propolis samples, originating from different location
in Morocco (Table 1), were obtained, as described by El-
Guendouz et al. [45], with slight modification. One gram
of each propolis sample was chopped into small pieces and
extracted by maceration using 30 mL of 70% ethanol and
maintained for one week at 37∘C under agitation (200 rpm).
The resulting solution was filtered under vacuum. A clear
solution, without further purification, was used for successive
analyses. First of all, polyphenol contents and antioxidant
activities were screened for all samples (twenty-four) while
only two samples were used for microbiological study (one
among the most active regarding the antioxidant activity
and polyphenol contents and the second among the weaker
samples regarding the same parameters).
2.3. Determination of Different Phenolic Groups
2.3.1. Total Phenol Content. The total polyphenol content
in propolis samples was determined using the method of
[46]. Hydro-alcoholic extracts (25 𝜇L) were mixed with 125𝜇L of Folin-Ciocalteu reagent (0.2 N) and 100 𝜇L of 7.5%
Na
2
CO
3
, and the absorbance was measured at 760 nm after
2 h of incubation at room temperature. The total polyphenol
content was expressed as mg per g of Ferulic Acid equivalents
using a calibration curve.
2.3.2. Total Flavones and Flavonol Content. The amounts of
flavones and flavonols in extracts were determined according
to the method [47], with minor modification. An amount
of 100 𝜇L of Al
2
Cl
3
(20%) was added to 100 𝜇L of extract,
and after one hour at room temperature the absorbance was
measured at 420 nm. Total flavones and the flavonols content
were calculated as quercetin equivalents (mg per g) using a
calibration curve.
2.3.3. Total Flavanones and Dihydroflavonol Contents. The
total quantification of flavanone and dihydroflavonol com-
pounds was performed as described by some authors [48].
Briefly, 75𝜇L of sample or standard and twomilliliters ofDNP
solution (one gram DNP in two milliliters 96% sulfuric acid,
diluted to 100 mL with methanol) were heated at 50∘C for
50 min. After cooling at room temperature, the mixture was
diluted to 10 mL with 10% KOH in methanol (w/v). A sample
of one milliliter of the resulting solution was added to 10 mL
methanol and diluted to 50 mL with methanol. Absorbance
was measured at 486 nm.
2.4. Antioxidant Activity
2.4.1. DPPH Free Radical Scavenging Activity. Scavenging
of the DPPH radical was assayed following the method of
[49], with somemodification. Solutions with different extract
concentrations were prepared and 25 𝜇L of each solution was
added to 150 𝜇L of DPPH solution (63.4 𝜇M) and 125 𝜇L
of 96% ethanol. Absorbance measurements were read at 517
nm, after 30 min of incubation time at room temperature.
Reduction of the amount of the DPPH radical present was
measured using a decrease in the absorption value at 517 nm.
The extract concentration providing 50% inhibition (IC
50
)
was calculated using a graph of the scavenging effect percent-
age against the extract concentration. The scavenging effect
percentage was calculated from the formula: [(A
0
-A
1
/A
0
) x
100], where A
0
is the absorbance of a negative control (blank
sample containing the same amount of solvent of extraction
and DPPH solution) and A
1
is the absorbance of the sample.
The percentage was plotted against the extract concentration,
and IC
50
values were determined (concentration of extract
able to scavenger 50% of the DPPH free radical).
2.4.2. ABTS Free Radical-Scavenging Activity. Determination
of the ABTS radical scavenging activity was carried out as
reported by [50]. Briefly, the ABTS radical was generated by
reaction of a 7 mM ABTS aqueous solution with K
2
S
2
O
8
(2.45 mM) in the dark for 16 h and adjusting the absorbance
at 734 nm to 0.7 at room temperature. Samples (25 𝜇L)
were added to 275 𝜇L of ABTS and the absorbance at 734
nm was read after 6 min. The capability to scavenge the
ABTS+ was calculated using the formula: ABTS scavenging
activity (%) = [(A
0
-A
1
)/A
0
] × 100 (%), where A
0
is the
absorbance of the control (ethanol 70% instead sample)
and A
1
is the absorbance in the presence of the sample.
The sample concentration providing 50% inhibition (IC
50
)
was obtained by plotting the inhibition percentage against
extracts concentrations.
2.4.3. Evaluation of Total Antioxidant Capacity by Phos-
phomolybdenum. The antioxidant activities of samples were
evaluated by the phosphomolybdenum method as described
by [51] and expressed relative to that of ascorbic acid. Briefly,
an aliquot of 50 𝜇L of propolis sample was mixed with one
milliliter of the reagent solution (0.6 M sulfuric acid, 28
mM sodium phosphate, and 4 mM ammonium molybdate).
Ethanol 70% was used as blank instead of propolis solution.
The reaction mixture was vortex-mixed and let to stand in
a water bath at 95∘C for 90 min. The tubes were cooled to
room temperature and the absorbance was measured at 695
nm. The experiment was conducted in triplicate and values
are expressed as mg equivalents of ascorbic acid per gram of
propolis.
2.4.4. Nitric Oxide Scavenging Activity. Thenitric oxide (NO)
scavenging activity was measured according to [52]. In this
method 50 𝜇L of different concentration of sample was added
to 50 𝜇L of 10 mM sodium nitroprusside in PBS into a 96-
well plate and the plate was incubated at room temperature
for 90 min. Finally, an equal volume of Griess reagent was
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added to each well and the absorbance was read at 532 nm.
Several concentrations of samples were made and the per-
centage inhibition calculated from the formula [1 - (Asample
- Asample blank)/(Acontrol - Acontrol blank)]x100, where (Asample -
Asample blank) is the difference in the absorbance of a sample,
with or without 10 mM sodium nitroprusside, and (Acontrol
- Acontrol blank) is the difference in the absorbance of the
PBS control, with or without 10 mM sodium nitroprusside.
The sample concentration providing 50% inhibition (IC
50
)
was obtained by plotting the inhibition percentage against
extracts concentrations.
2.4.5. ChelatingMetal Ions. Thedegree of chelating of ferrous
ions by the propolis samples was evaluated according to
[53]. Briefly, 0.1 mL of different concentration of samples
was incubated with 0.05 mL of FeCl
2
.4H
2
O (2 mM). The
addition of 0.2 mL of 5 mM ferrozine initiated the reaction,
and after10 min, the absorbance at 562 nm was measured.
An untreated sample served as the control. The percentage of
chelating ability was determined according to the following
formula: [(A
0
-A
1
)/A
0
x100], in which A
0
is the absorbance of
the control and A
1
is the absorbance of propolis sample. The
values of IC
50
were determined as reported above.
2.4.6. Scavenging Ability of Superoxide Anion Radical. Scav-
enging ability of superoxide anion radical was evaluated as
previously reported by [54]. Superoxide anions were gener-
ated in a nonenzymatic PMS-NADH system by oxidation of
NADH and assayed by reduction of nitroblue tetrazolium
(NBT). The superoxide anion was generated in 300 𝜇L of
phosphate buffer (19 mM, pH=7.4) containing NBT (43 𝜇M)
solution, NADH (166 𝜇M) solution, and different concentra-
tions of propolis.The reactionwas startedwith the addition of
PMS solution (2.7 𝜇M) to the mixture. The reaction mixture
was incubated at room temperature for 10 min and the
absorbance reading was performed at 560 nm in a microplate
reader (Tecan Infinite M200, Tecan, Austria). The percentage
of inhibition was calculated using the following equation:
Inhibition = [(A0-A1)
A
0
] x100 (%) (1)
where A
0
is the absorbance of the control (without sample)
and 𝐴
1
is the absorbance in the presence of the sample.
Tests were carried out in triplicate. The sample concentration
providing 50% inhibition (IC
50
) was obtained by plotting the
inhibition percentage against extracts concentrations.
2.4.7. Hydrogen Peroxide Scavenging Capacity. The ability of
the propolis extracts to scavenge hydrogen peroxide was
determined according to the method of [55], with slight
modification. A solution of hydrogen peroxide (40 mM) was
prepared in phosphate buffer (50 mM, pH=7.4). Fifty 𝜇L of
each propolis concentration was added to a hydrogen per-
oxide solution (0.6 mL, 40mM), one milliliter of phosphate
buffer (50 mM, pH=7.4), and 1650 𝜇L of distilled water.
Absorbance of hydrogen peroxide at 230 nm was determined
20minutes later against a blank solution containing the phos-
phate buffer without hydrogen peroxide. Tests were carried
out in triplicate and the values of IC
50
were determined as
reported above.
2.4.8. Scavenging Ability of Peroxyl Radicals by the Oxygen
Radical Absorbance Capacity (ORAC). An ORAC assay is
based on the capacity of antioxidants in a sample to quench
peroxyl radicals generated from thermal decomposition of
AAPH. The ORAC method used fluorescein (FL) as the
fluorescent probe following the method of [56]. An amount
of 0.414 g of AAPH was dissolved in 10 mL of phosphate
buffer 75 mM (pH 7.4) and kept in an ice bath. A solution
of fluorescein (0.00419 mM) was prepared in phosphate
buffer and kept in the dark at 4∘C. A new concentration
(8.16×10−5 mM) was prepared before reactions. A Trolox
standard (0.02 M) was prepared in phosphate buffer and
diluted to 50, 25, 12.5, and 6.25 𝜇M. As the ORAC assay
is extremely sensitive, the samples must be diluted (1/1,000;
1/10,000) before analysis to avoid interference. An amount of
150 𝜇L of a fluorescein working solution, 25 𝜇L of sample, and
either a blank (Milli-Q water) or a standard were mixed on a
plate, which was then covered with a lid and incubated in a
preheated (37∘C) microplate reader for 10 min. An amount
of 25 𝜇L of AAPH solution was then added to each well. The
microplate was shaken for 10 s and then the fluorescence was
read every minute for two hours at an excitation wavelength
of 485 nm and an emission wavelength of 527 nm. The net
area under the curve (AUC) of the standards and samples
was calculated. A standard curve was obtained by plotting
Trolox concentrations against the average net AUC of two
measurements for each concentration. Final ORAC values
were calculated using a regression equation between the
Trolox concentration and the net AUC and are expressed as𝜇mol of Trolox/g propolis.
2.4.9. Reducing Power Assay. The reducing power was deter-
mined according to the method described by [57], with
slight modifications. The extracts (50 𝜇L) were mixed with
500 𝜇L of 0.2M sodium phosphate buffer (pH=6) and 500𝜇L of 1% potassium ferricyanide (K
3
FeCN6). The mixture
was incubated at 50∘C for 20 min. After 500 𝜇L of 10%
trichloroacetic acid was added, the mixture was centrifuged
for 10 min at 3000 rpm. 500 𝜇L of the supernatant liquid was
mixed with 500 𝜇L of distilled water and 100 𝜇L of 0.1% ferric
chloride.The absorbance of the mixture was measured at 700
nm.
2.5. Antimicrobial Activity. After the screening of polyphenol
content and the antioxidant activities of all propolis samples,
only two samples were chosen for microbiological test (sam-
ples 1 and 7) based on the previous test performed.
2.5.1. GC-MS Analysis of Propolis Extract. GC-MS analysis
was done for the two samples (1 and 7) chosen for the
antimicrobial assays. The analysis was performed with a
Hewlett–Packard gas chromatograph 5890 series II Plus
linked to a Hewlett–Packard 5972 mass spectrometer system
equipped with a 30 m long, 0.25 mm i.d., and 0.5 𝜇m
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film thickness HP5-MS capillary column. The work con-
ditions were the same as previously reported [58]. Semi-
quantification was carried out by internal normalisation with
the area of each compound. The addition of individual areas
of the compounds corresponds to 100% area. Compound
identification was performed using commercial libraries and
comparison of mass spectra and retention times of reference
compounds.
2.5.2. Bacterial Strains and Growth Conditions. The bacterial
strains were cultivated in BHI. For solid media, agar was
added at 1.5 %, w/v. The bacterial strains of S. aureus used
in this study are indicated in Table 5. Bacteria were stored in
BHI supplemented with 25 % (v/v) glycerol at -80∘C. Prior
to use, bacteria were transferred to fresh BHI agar plates and
incubated at 37∘C.ChromobacteriumviolaceumCV026 (HgR,
cvil:Tn5 xylE, KanR and spontaneous resistance StrR) was a
gift from Professor Mondher EL Jaziri, Plant Biotechnology
Laboratory, Universite´ Libre de Bruxelles, Belgium.
2.5.3. Disc Diffusion Method. A paper disc diffusion assay to
assess the preliminary antibacterial activity of two propolis
samples (most active (1) and the less active (7) samples
regarding their total phenol content) was performed accord-
ing to [59]. S. aureus cultureswere incubated overnight before
theOD
600
was adjusted to 0.3-0.4.Hundredmicroliters of this
bacterial culture were then spread on BHI agar plates and left
to dry at room temperature for a few minutes. Then sterile
filter paper discs were placed over the plate and propolis
extracts at concentration of 0.24, 0.49, 0.73, and 0.98 mg/mL
were loaded onto the discs. Diluted ethanol 70% was used as
a negative control and the chloramphenicol disc (30 𝜇g/mL)
as a positive control. The plates were incubated at 37∘C for 24
hours. After the incubation time the inhibition zones were
determined. Three biological and three technical replicates
(N=9) were done.
2.5.4. Determination of the Minimum Inhibitory Concen-
tration. The minimum inhibitory concentration (MIC) of
propolis samples (1 and 7) was determined using a microdi-
lution method according to [60]. Concentrations of propolis
were 0.24; 0.36; 0.49; 0.61; 0.73; 0.98; and 1.22 mg/mL.
Each S. aureus strain was cultivated in BHI agar plates for
24 h at 37∘C. A loop of isolated bacterial colonies from
each plate was inoculated into 10 mL of BHI broth, and
the culture was incubated overnight in a shaking water
bath at 37∘C, to prepare a suspension with a turbidity of
0.5 of the McFarland scale (108 CFU/mL). 100 𝜇L of the
overnight bacterial culturewas centrifuged, and the pelletwas
resuspendedwith the same volume ofmedium supplemented
with the appropriate propolis concentration, then 20𝜇L of the
bacterial suspension was inoculated into each well of a flat-
bottom microplate (Greiner, Labortechnik, Frickenhausen,
Germany) previously filled with 180 𝜇L of BHI supplemented
with propolis at the proper concentration. Wells containing
the culture medium supplemented with ethanol 70% or chlo-
ramphenicol (30 𝜇g/mL) were included, as control. Negative
control was constituted by the culture in BHI and no propolis
added. Three biological and three technical replicates for
each strain were used (N = 9). The growth was followed
by spectrophotometry (OD) in a microplate reader (Tecan
Infinite M200, Tecan, Austria) at optical density of 600 nm.
TheMIC value was considered as the lowest concentration of
propolis that inhibits the visible bacterial growth (no increase
in the OD after 24–48 h). The lowest concentration that did
not allowed the recovery of cells in agar plates was considered
the minimum bactericidal concentration (MBC).
2.5.5. Effect of the Adaptation of S. aureus Strains on the
Susceptibility to Propolis Extract and Antibiotics. According
to the disc diffusion and MIC value results the remain-
ing microbiological tests will be done only with sample 1.
Adaptation procedure (successive passage) was performed
as described by [60]. The tested concentrations of propolis
(sample 1) were 0.12; 0.24; 0.36; 0.49; and 0.61 mg/mL. Each
bacterial strain was cultivated on BHI agar plates at 37∘C
during 24 h. 10 mL of BHI broth was inoculated with a
loop of isolated colonies from each plate, and the culture
incubated overnight. 300 𝜇L of the overnight bacterial culture
was centrifuged (2,790 x g, 5 min at 4∘c) and the pellet
was resuspended in 300 𝜇L BHI supplemented with 0.12
mg/mL of propolis extract and then inoculated into 10 mL
of BHI with the same concentration of propolis extract.
The bacterial culture was incubated for 24 h in a shaking
water bath at 37∘C and then was transferred sequentially at
the same concentration of propolis extract for 4 days. The
bacterial growth at each successive passage was followed by
spectrophotometry at OD
600
nm. Following the four days of
sequential passages, bacteria were transferred to BHI with
higher concentration of propolis extract. Agar disc diffusion
was performed each day of the sequential passages of each
concentration. The purpose was to evaluate the bacteria
susceptibility to antibiotics and eventual development of
antibiotic resistance (gentamicin, erythromycin, chloram-
phenicol, and tetracycline). These procedures were repeated
until bacteria cease to grow. Culture with no propolis extract
was used as control in parallel. Three independent replicates
were performed.
2.5.6. Influence of Propolis Extract on Adherence. The influ-
ence of propolis extract (sample 1) on adherence of S. aureus
was performed according to [61] with slight modifications.
Briefly, 200 𝜇L of an overnight culture (OD = 0.4-0.5),
prepared as described above, was centrifuged and the pellet
was resuspended with medium supplemented with propolis
extract at the MIC value (0.36 mg/mL), chlorhexidine 0.2%
(positive control), and BHI only (negative control). The
prepared culture was inoculated into each well of a flat-
bottom microplate and left to adhere for 30 min at room
temperature in a flow cabinet. After incubation nonadherent
cells and residues of media component were removed by
washing the wells with sterile PBS. Wells were air dried for
15 min.The adherent cells were heat-fixed at 80∘C for 30 min,
stained with 0.1% crystal violet, and kept for 10 min to react.
The wells were washed again before the dissolution of the
stain by addition of ethanol–acetone (80:20), and the ODwas
determined with a microplate reader at 595 nm.
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2.5.7. Screening of Propolis Extract for Anti-QS Properties.
This assay was performed as described by [62] with some
modifications. Chromobacterium violaceum CV026 was cul-
tured on LB agar plates at 30∘C during 24 h. LB broth was
inoculated from each plate, and the culture was incubated
overnight in a water bath at 30∘C. Eight mL of the overnight
culture was adjusted to OD
600
of 1.2 and transferred into 40
mL of warm molten LB agar, followed by the addition of N-
hexanoylhomoserine lactone (C6-HSL) at final concentration
of 0.12 𝜇g/mL. The agar mixture was mixed and poured into
the Petri dish and left to solidify inside a flow cabinet for
one hour. Small wells were made on the solidified agar plate
with the bottom of a Pasteur pipette.Wells were filled with 40𝜇L of propolis extract at the concentration 0.24; 0.36; 0.49;
0.61; 0.73; 0.98; and 1.22 mg/mL. The plate was incubated for
24 hours at 30∘C to check for the violacein inhibition. The
positive control for the QS inhibition in this assay was (+)-
catechin and ethanol 70% diluted was used as the negative
control.
2.5.8. Influence of Propolis Extract on Virulence. The effect of
adaptation of propolis (sample 1) on virulence of S. aureus
strains was determined using larvae of the Greater Wax
Moth Galleria mellonella (Lepidoptera: Pyralidae) according
to [63]. The insects weighing between 250 and 350 mg were
reared during the first and second instars with pollen and wax
then with an artificial diet containing a mixture of glycerol,
honey, water, dry dog food, and wheat bran. It is noted
that the development of the insects was carried out in the
dark at 30∘C. S. aureus strains were previously adapted to
subinhibitory propolis concentration (0.24 mg/mL) for three
successive passages. Each S. aureus culture (108 CFU mL−1)
was centrifuged at 2,790 x g for 5min at 4∘C, then the bacterial
cells were resuspended in one milliliter of sterile PBS. First
larvae were superficially disinfected with ethanol at 70% v/v
and then were infected with 10 𝜇L of the initial suspension
(106 CFU) by injection on the second right proleg using a 50𝜇L microsyringe. Larvae were placed in sterile Petri dishes
at 37∘C and death checked every 24 h for 5 days. Death was
considered when no response to touch was observed. Three
independent experiments were carried out. PBS was injected
to the insect control.
2.6. Statistical Analysis. Datawere analysed byANOVAusing
the SPSS 23.0 program (Inc., Chicago, IL, USA). Statistical
significance was set as p< 0.05; when the analysis was
statistically significant, Tukey’s post hoc test was done. The
survival data were treated using GraphPad Prism 5 statistical
software.
3. Results and Discussion
3.1. Phenols. Table 1 depicts the phenol content of Moroccan
propolis samples. Samples 17, 23, and 1 had the highest con-
centrations of total phenols (265.37, 264.80, and 205.82 mg
ferulic acid equivalent (FAE)/g, respectively), total flavones
and flavonols (129.60, 80.97, and 53.50mgQE/g, respectively),
and total dihydroflavonols and flavanones (6.67, 15.95, and
7.69 mg EE/g, respectively). Among these samples, propolis
extract 1 had the lowest concentrations of total phenols,
flavones, and flavonols, whereas propolis extract 17 had
the lowest concentration of dihydroflavonols and flavanones
(Table 1). Shortly, samples 17 and 23 had similar amounts of
total phenols, but sample 17 had higher flavones and flavonols
and lower concentrations of flavanones and dihydroflavonols
than sample 1. The polyphenol content of these samples is
superior to those described by [47]. In this case, 91.22 mg
caffeic acid equivalent (CAE)/g was the best value found
among the 14 samples of propolis collected at different places
of Morocco. With the exceptions of samples 24, 21, 7, and
12 with the lowest concentrations of total polyphenols (7.06-
9.53 mg FAE/g) and those with the highest concentrations
of the same metabolites, the remaining samples had similar
amounts of phenols to those reported for the neighbor
country, Algeria, 10–47 mg gallic acid (GA)/g [17], and
superior to the majority of samples forMorocco (0.7–65.7mg
CAE/g) [47]. Lower amounts of flavonoids were also reported
by some authors [17, 47]. When compared to the results
presented in the present work, the highest concentration of
total flavonoids detected by these authors did not surpass 35
mg QE/g for Moroccan propolis or 30 mg QE/g for Algerian
propolis.
3.2. Antioxidant Activity. The antioxidant activity was
checked through diverse methods: capacity for scavenging
diverse free radicals (DPPH, ABTS, superoxide, NO,
peroxyl), or chelating activity. The results are presented in
Table 2. The capacity for reducing ion metals is depicted in
Figure 1.
The results will be only compared with those from
Mediterranean origin found in articles listed in the ISI Web
of Knowledge [15–17, 27, 28, 31, 34, 47, 50, 64–70].
Among all propolis extracts, sample 1 had the best total
antioxidant activity (48.95 meq Ascorbic Acid Equivalent /g)
(Table 2), higher than those already reported for Moroccan
propolis [34]. This sample, along with samples 10, 17, and 23,
presented the lowest IC
50
values for the assays that measure
the ability for scavenging ABTS and DPPH free radicals,
that is, those that showed the best capacity for scavenging
such free radicals. Samples 13-16 also had significant higher
capacity for scavenging the ABTS free radicals (Table 2).
In the DPPH and ABTS assays, the lowest IC
50
values
(0.007–0.024 mg/mL and 0.002–0.044 mg/mL, respectively)
which correspond to the best activities are within the range
found for propolis samples from Morocco [47]. For the
DPPHmethod, Algerian propolis extracts had lower activity
(IC
50
values ranging from 32.3 to 600 𝜇g/mL) [15]. In
the same work, these authors reported that the purified
compounds had higher activity than the extracts, being
kaempferol and phenetyl-(E)-caffeate those possessing the
best activities, with IC
50
of 4.2 and 9.9 𝜇g/mL, respectively.
The same authors found a direct correlation between the
amount of phenols, including flavonoids, and the capacity
for scavenging the free radicals. For scavenging about 60% of
DPPH free radicals, [17] reported that it was necessary at least
100 𝜇g/mL of ethanolic extract of propolis fromAlgeria. Like
[15], Benhanifia et al. [17] also found a remarkable correlation
between phenol content and antioxidant activity, measured
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Figure 1: The reducing power of the hydro-alcoholic extracts of propolis from different areas of Morocco. (a) Group of samples with the best
reducing power; (b) group of samples with the lower reducing power.
through the capacity for scavenging DPPH free radicals, but
absent in the capacity for reducing ferric ions. The authors
[16] found as IC
50
value, 25 𝜇g/mL, for an ethanolic extract of
propolis from Algeria, closer to those reported in the present
work.
When the antioxidant activity was evaluated through the
capacity for scavenging ABTS free radicals, beyond those
samples with the highest activity for scavenging DPPH free
radicals (1, 10, 17, and 23), other ones were equally good
scavengers of ABTS, such as 13-16 (Table 2). These samples
did not possess as high amounts of phenols or flavonoids as
the remaining samples. These results reveal the importance
of some compounds and/or their functional groups present in
the extracts on the activity and that show behaviour somehow
different in the presence of DPPH or ABTS free radicals
[64, 65].
The capacity for scavenging DPPH and ABTS, cheap and
simple methods, can give information about the antiradical
activity of samples; nevertheless they are not natural radicals,
whereby the evaluation of the capacity of samples for scaveng-
ing ROS produced by the organisms is with a high interest.
The most important reactive molecules include superoxide
and hydrogen peroxide.
Samples 10 (IC
50
= 0.253 mg/mL) and 23 (IC
50
= 0.213
mg/mL) had the best capacity for scavenging superoxide
radical anions, poorer when compared to the best IC
50
values
found for samples fromMorocco (IC
50
= 0.15 mg/mL), previ-
ously reported [34], and markedly poorer to those reported
by Gu¨lc¸in et al. (2010) for propolis samples from Turkey
[31], with IC
50
= 9.89 𝜇g/mL. Mavri et al. [28] also evaluated
the capacity of Slovenian propolis for scavenging superoxide
anion radicals, showing that 0.02 mg/mL of propolis phenols
present in the extracts were able to scavenge between 6.8
and 21% of superoxide anion radicals, depending on these
percentages of the ethanol: water ratio of the extraction
solvent.
The capacity for scavenging hydrogen peroxide was sig-
nificantly higher for samples 1 (IC
50
= 0.086 mg/mL) and
23 (IC
50
= 0.048 mg/mL), being such values about tenfold
higher than those reported by [31] for Turkish samples (6.54𝜇g/mL), and therefore with poorer ability for scavenging
H
2
O
2
. Potkonjak et al. [27] determined the antioxidant
activity of commercial propolis extracts from Serbia through
direct current polarography, expressed in H
2
O
2
equivalent
(the volume of H
2
O
2
that corresponds to 1.0 mmol/L H
2
O
2
decrease). The values found by the authors ranged from 1.71
to 8.00 𝜇L. Once the unities are different, it is not possible to
compare the results obtained by [27] with the values obtained
in the present work.
The capacity of samples 1, 10, and 23 for scavenging
superoxide and hydrogen peroxide not only prevents the gen-
eration ofmore reactive species, such as hydroxyl radicals, but
also avoids the interaction between ROS and biomolecules
[66].
The best capacity for scavenging peroxyl free radicals,
measured through the method called ORAC, that measures
the capacity for scavenging peroxyl radicals, was detected
for samples 17 (1723.289 𝜇mol TE/g) and 23 (1616.654 𝜇mol
TE/g), inferior to themaximal observed forMoroccan propo-
lis [47]. The best antiradical capacity of those samples (17
10 Evidence-Based Complementary and Alternative Medicine
Table 3: Spearman correlation coefficients among total phenols and flavonoids and antioxidant activities.
Total phenol Flavone+Flavonol Flavanone+Dihydroﬂavonol
Total phenol 1 0.965∗∗ 0.857∗∗
Flavone+Flavonol 0.965∗∗ 1 0.849∗∗
Flavanone+Dihydroﬂavonol 0.857∗∗ 0.849∗∗ 1
Molybdate 0.458∗ 0.440∗ 0.705∗∗
DPPH -0.855∗∗ -0.828∗∗ -0.773∗∗
ABTS -0.691∗∗ -0.634∗∗ -0.645∗∗
Chelating assay 0.359∗ 0.415∗ 0.394∗
Nitric oxide -0.951∗∗ -0.941∗∗ -0.851∗∗
Hydrogen peroxide 0.735∗∗ -0.807∗∗ -0.920∗∗
ORAC 0.868∗∗ 0.791∗∗ 0.778∗∗
Superoxide scavenging -0.675∗∗ -0.567∗∗ -0.737∗∗
∗ Correlation is significant at the p < 0.05 level. ∗∗ Correlation is significant at the p < 0.01 level.
and 23) is revealed to be important since they may prevent
the propagation of lipid peroxidation caused by the peroxyl
radicals [67].
Only sample 17 was significantly better as NO scavenger
(IC
50
= 0.025 mg/ml) when compared to the remaining
samples, whilst sample 13 presented the best chelating activity
(IC
50
= 0.251 mg/ml) (Table 2). The capacity for scavenging
NOradicalswas better than those found by [34] forMoroccan
propolis (IC
50
=0.08-2.90mg/mL).Thebest chelating activity
found in the present work was inferior to that previously
reported (IC
50
= 0.13 mg/mL) also for Moroccan propolis
[34] and significantly inferior to those found for Turkish
samples (0.012mg/mL) [31], but better when compared to the
Slovenian propolis (2 mg/mL) [28].
The capacity of sample 17 for nitric oxide quenching
can avoid the generation of peroxynitrite, in the presence of
superoxide anion radicals, that irreversibly binds to proteins
impairing cellular function [68].
The presence of iron ions and hydrogen peroxide may
trigger the formation of the most reactive hydroxyl radicals,
through the Fenton reaction; therefore the absence of these
ions as well as other transition metal ions, such as copper, is
important. Sample 13 is revealed to be the most active in what
concerns the capacity for chelating iron ions [68].
Two main groups may be considered in terms of capacity
for reducing Fe3+ to Fe2+ by propolis extracts (Figures 1(a)
and 1(b)). Samples 1, 10, 13, 14, 15, 16, 17, 20, 22, and 23
are in group one (Figure 1(a)), being those with the best
reducing capacity (for the higher concentration used, the
absorbance was ≥ 1, at 𝜆=700 nm); and the remaining
samples belong to group two, that is, those with significant
lower reducing activities (Figure 1(b)). It is noteworthy to
refer that with the exception of samples 20 and 22, which
were introduced in the first group, the remaining samples
belonging to the same group are also those with the best
capacity for scavenging ABTS free radicals. Such may partly
explained by themechanism involved in the reaction between
ABTS free radicals and compounds, which is predominantly
based in single electron transfer mechanism, that is, the
same mechanism that occurred during the reduction of
Fe3+ to Fe2+. At least two factors may have contributed
to the lower number of samples (1, 10, 17, and 23) with
relative high capacity for scavenging DPPH free radicals
when compared to the number of samples with significant
higher capacity for scavenging ABTS free radicals: (a) the
mechanisms involved in the reaction between DPPH and
compounds are amix of single electron transfer and hydrogen
atom transfer mechanisms; and (b) the reaction between
extracts, constituted by several compounds, and DPPH is less
than the total reactivity of individual compounds [65].
A negative correlation between IC
50
values (DPPH,
ABTS, NO, and superoxide) and phenol content (p<0.01) was
found, which means higher activity with higher concentra-
tions of phenols.The same correlation was observed between
the same values and the amounts of flavonoids (flavanone, di-
hydroflavonols, flavones, and flavonols) (Table 3). A positive
correlation was observed between the values for ORAC
test and the concentrations of phenols, independent on the
type, meaning an increase of the capacity for scavenging
free peroxyl radicals and phenols. The same was observed
between the amounts of phenols and the total antioxidant
activity determined by themolybdatemethod, although there
is higher correlation between the values and the amounts of
flavanones and dihydroflavonols (Table 3). A positive correla-
tion between IC
50
values and chelating activity was found. In
this case, it seems that phenols, independent on the type, have
a negative effect on the chelating activity, impairing it. The
chelating efficiency of phenols on Fe2+ depends on the num-
ber of hydroxyl groups on the benzene ring as well as on the
hydroxyl substitution in the ortho position [69]. An absence
of correlation between chelating activity and phenol amounts
was already reported by [50] for commercial honeys for
Morocco. Although the presence of high levels of polyphenol
in cocoa extracts, Andu´jar et al. [69] also found an absence of
ability of samples for chelating Fe2+ ions. The results found in
the present work suggest that the observed chelating activity
can be assigned to compounds other than phenols.
3.3. Antimicrobial Properties
3.3.1. Antistaphylococcal Activity of Propolis. The results of
the antibacterial activity of propolis extracts against S. aureus
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strains are indicated in Table 4. Our results showed a visible
inhibition zone, particularly sample 1, at all concentrations
tested against the four strains. The highest inhibition zone
(27.00± 1.52 mm; 25.67± 0.57mm; 31.67± 1.73mm and 32.33± 1.51mm)was recorded from sample 1 at 0.98mg/mL, higher
than chloramphenicol (26.00 ± 2.51 mm; 19.00 ± 0.57mm;
24.33± 0.01mmand 24.67± 2.29mm) forMRSA strains, while
sample 7 showed a lower inhibition zone (14.33±0.57 mm;
16.33±4.93 mm; 16.00±1.01 mm; and 17.67±2.88 mm) at the
same concentrations. At concentration of 0.24 mg/mL and
0.49 mg/mL, the inhibition zones were very small <20mm
for sample 1 and <10 mm for sample 7 (data not shown).
Ethanol (negative control) did not show antibacterial activity,
as expected.The diameters of inhibition zones were increased
with respect to the volume of the extracts.
The best activity found for sample 1 was confirmed
through the values of MIC and MBC found. Propolis sample
1 showed a MIC value of 0.36 mg/mL and the MBC ranged
from 0.98 to 1.22 mg/mL for S. aureus tested strains.
No differences were observed between the MIC values of
sample 1 (0.36 mg/mL) for all strains tested. However, the
MBC values determined for S. aureusMRSA2, MRSA15, and
MRSA16 were 1.22 mg/mL, except for S. aureus ATCC 6538,
which was 0.98 mg/mL. In contrast, the susceptibility of S.
aureus strains to sample 7was not proved.The concentrations
tested did not affect the bacterial growth.
The differences found in the activities between samples 1
and 7 may result for their distinct chemical composition. In
Figure 2, it is possible to see that sample 7 was predominantly
constituted by sugars and their derivatives (68.5%), whereas
sample 1 had as main group of secondary metabolites, the
flavonoids, diterpenes, and phenolic acid esters [45].The high
percentage of sugars is mainly constituted by monosaccha-
rides (52.6%), which may reveal appreciable quantities of
honey and therefore an inadequate harvesting of propolis.
Sample 7 had also triterpenes, particularly sterols rep-
resented particularly by lanosterol lupeol (3.5%), (3-𝛽-OH)
(2.9%), lanosterol (3-𝛼-OH) (1.2%), and 𝛼-amyrin (0.4%).
The diterpenes were the third abundant group in the propolis
component and mainly represented by imbricataloic acid,
totarol, and dehydroabietic acid (1.3%, 1.2%, and 0.3%,
respectively) (Table S1). This propolis sample had also fatty
acids [hexadecanoic acid (2.8%), octadecanoic acid (1.9%),
octadecenoic acid (0.5%), and tetracosanoic acid (0.8%)] and
aromatic acids [benzoic acid (1.2%)].
The values of MIC found for sample 1 are higher than
those reported for ethanolic extracts of propolis from Taiwan
and Iran where MIC values ranged from <3.75 to 60 𝜇g/mL
and 205 𝜇g/mL, respectively [70, 71] and lower than that
from Canada (MIC = 2.74 mg/mL) for S. aureus strains
[72]. The antimicrobial activity of propolis extracts has been
attributed to a synergism effect of phenol compounds, includ-
ing caffeic acid and caffeic acid phenetyl ester, and flavonoids
[40]. However, in sample 1, diterpenes predominate, mainly
isocupressic acid [58]. The results obtained may, therefore,
be attributed to diterpenes along with phenols, by either
synergism or antagonism. The antistaphylococcal activity
of Mediterranean propolis, from Malta, was better than
Bulgarian poplar propolis [73]. The authors, also, attributed
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Figure 2: Group of compounds present in propolis samples S1 and
S7.
this better activity to the possible presence of relative high
amounts of diterpenes in Maltese propolis.
3.3.2. Adaptation to Subinhibitory Concentrations of Propolis
Extract on the Induction of Resistance to Propolis Extract or
Antibiotics. In order to evaluate the impact of sequential
exposure of S. aureus strains to propolis on developing resis-
tance against this natural product, the effect of the adaptation
of the S. aureus strains on the susceptibility to propolis
extract was investigated. S. aureus ATCC 6538 was able to
overcome just four passages at the MIC value (0.36 mg/mL)
of propolis extract after the sequential passages at 0.12, 0.24,
and 0.36 mg/mL, but failed to overcome the following lethal
concentration of 0.49mg/mL, after the first passage (Table 5).
Adapted cells of MRSA15 and MRSA16 strains were able to
overcome just four passages of the concentration 0.49mg/mL
after the same sequential passages. The MRSA 2 cells were
able to overcome the four passages at 0.49 and 0.73 mg/mL.
According to the EUCAST breakpoint tables (2016), the four
S. aureus strains showed a susceptible profile to chloram-
phenicol, gentamicin, tetracycline, and erythromycin after
the adaptation with different concentration of propolis (data
not shown).
Beyond the antimicrobial activity of propolis extracts
against Staphylococcus sp. and other microorganisms, they
have also been reported to potentiate the action of antibi-
otics [74]. Propolis is widely used as ingredient in chewing
gums, toothpastes and oral sprays, shampoos, soaps, and
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Table 5: Impact of continued exposure of Staphylococcus aureus strains on increasing concentrations of propolis∗.
Passages Concentration of propolis sample (mg/mL)
0.12 0.24 0.36 0.49 0.73
Staphylococcus aureusATCC 6538
1∘ 72.44±21.87a 42.81±1.41a 40.24±9.81a 14.22±0.43
NA2
∘ 36±10.72a 50.88±7.26a 61.33±10.00a NG
3∘ 87.17±61.12a 100.52±47.22a 57.33±15.19a
4∘ 24.71±6.5a 103.68±16.5a 74.35±18.23a
Staphylococcus aureusmethicillin-resistant 2 (MRSA 2)
1∘ 114.09±35.26a 131.95±24.28a 5.33±0.91a 26.35±3.37a 35.92±18.65a
2∘ 139.7±45.72a 99.90±4.81a 48.49±15.95b 39.26±3.66a 8.98±3.02a
3∘ 75.38±13.02a 86.15±16.15a 55.75±24.95b 46.59±4.55a 31.46±26.68a
4∘ 105.17±21.68a 119.59±28.23a 33.20±3.82ab 83.55±20.67b 0.73±0.45a
Staphylococcus aureusmethicillin-resistant 15 (MRSA 15)
1∘ 123.65±40.98a 125.40±15.72b 30.74±0.48a 32.74±27.93a
NA2
∘ 100.45±58.78a 124.64±9.27b 39.02±84.66a 27.13±7.29a
3∘ 110.22±48.25a 123.99±36.06b 33.38±9.14a 18.38±15.47a
4∘ 62.66±2.06a 65.66±11.69a 42.03±12.93a 0.59±0.40a
Staphylococcus aureusmethicillin-resistant 16 (MRSA 16)
1∘ 129.79±14.65b 43.57±6.84a 46.80±21.55a 43.22±8.18c
NA2
∘ 113.68±13.42b 96.39±13.47b 45.30±17.68a 22.09±10.66bc
3∘ 57.71±7.81a 66.98±6.86ab 38.99±4.94a 21.60±9.03b
4∘ 92.88±28.63ab 57.50±15.60a 83.80±29.52a 0.28±0.25a
∗Fold change in growth at each passage is indicated as the ratio between the OD at T24 and the OD at T0 (ODT24/ODT0).NG: no growth; NA: not applied.
Data are representative of three independent replicates. For each strain, data in the column with different letters are significantly different (p < 0.05).
cosmetics. The repeated utilization of these products by
people leads to a continuous exposure of microorganisms,
including pathogens when an infectious disease is declared,
to the subinhibitory concentrations of propolis. With this
vast utilization of propolis under several forms, it is very
important to clarify the impact of this repeated exposure of
pathogens to propolis and their constituents on the develop-
ment of resistance, to either propolis or their components and
antibiotics. This sort of studies has been carried out by some
authors [60, 75, 76] but with essential oils and/or their main
components and controversial results have been reported.
In the present work, it is clear that the sequential exposure
to sublethal doses of propolis from Morocco did not result
in the development of resistance to the propolis itself or to
antibiotics (chloramphenicol and tetracycline for all strains;
an erythromycin for S. aureusATCC6538 andMRSA2).With
such results, care must be taken with the frequent utilization
of these kinds of natural products associated with some
antibiotics, in the presence of particular MRSA strains.
3.3.3. Influence of Propolis Extract on Adherence. The results
of the impact of propolis on the adherence ability of S. aureus
strains are illustrated in Figure 3. The adherence of the cells
of ATCC 6538 strain was not affected by propolis exposure in
comparison to theMRSA strainswhose adherencewas signif-
icantly impaired. In contrast, the exposure to chlorhexidine
(0.2%, w/v) not only did not inhibit the adherence of all the
S. aureus strains, but have boosted it significantly (p < 0.001)
in comparison with the control. This finding is particularly
interesting since a decrease in the susceptibility of clinical
isolates of S. aureus has been reported [77, 78].The adherence
inhibition ofMRSA strains by propolis was strain dependent,
and the adherence of MRSA15 was particularly affected (p< 0.001) in comparison with the control. The adherence of
MRSA16 was also impaired by the propolis extract (p < 0.01),
but the adherence inhibition of the strain MRSA2 strain was
lower (p < 0.05).
The ability to adhere of eight S. aureus strains was
impaired in the presence of several concentrations of ethano-
lic extracts of propolis from Romania [12]. The prevention
of biofilm formation promoted by propolis was also found
for other microorganisms being also such property dose-
dependent [12, 79, 80]. The geographic origin of propolis is
another factor responsible for the variability of inhibition
of biofilm formation, that is, dependent on the chemical
composition. Those authors related the activities found with
the chemical amounts of several types of phenols present
in propolis samples. In contrast to the results reported by
these authors, in the present work the presence of propolis
extract did not impair the adherence of S. aureus ATCC6538
cells; nevertheless the diverse strains of MRSA cells were
inhibited to form biofilm in the presence of propolis of the
same origin. Diterpenes along with phenols, the main group
of compounds of our extract of propolis (sample 1), may have
a role in the activity found.
Bacterial biofilm formation is linked to the quorum-
sensing system (QS), a cell-cell communication system that
modulates gene expression and works in a cell density
14 Evidence-Based Complementary and Alternative Medicine
ATCC6538 MRSA2 MRS15 MRSA16
Control
Propolis
Chlorhexidine
O
D
 5
95
nm
0.0
0.5
1.0
1.5
2.0
2.5
∗∗∗
∗∗∗
∗∗
∗∗∗
∗∗∗
∗∗∗
∗
Figure 3: Impact of propolis extract (sample 1) at the MIC value
(0.36mg/mL) on the adherence ability of four Staphylococcus aureus
strains. Data are the mean of three independent experiments (n =
12). Error bars represent the standard deviation. ∗ p < 0.05; ∗∗ p <
0.01;∗∗∗ p < 0.001, statistically significant when compared with the
control.
dependent mode [81]. In staphylococci, the QS mechanism
comprises the accessory gene regulator (agr) locus that
controls the production of a small auto-inducing signal
peptide (AIP) [82]; how propolis impairs biofilm formation
by disrupting the QS system in S. aureus needs further
investigation.
3.3.4. Screening of Propolis Extract for Anti-Quorum Sensing
Properties. Theanti-QS activity of propolis extract was deter-
mined by assessing the violacein production by C. violaceum
and the results are shown in Figures 4(a) and 4(b). Loss of
the purple pigment inC. violaceum indicates the inhibition of
QS by the propolis extract. Control wells containing catechin
and ethanol were included. The seven concentrations 0.24;
0.36; 0.49; 0.61; 0.73; 0.98; and 1.22 mg/mL showed halo zone
on the purple background. Therefore, the highest inhibition
zone (15.43±1.57mm) was observed for the concentration
1.22 mg/mL followed by 10.5±1.00 mm for the concentration
0.98 mg/mL. No inhibition was apparent with ethanol (Fig-
ure 4(a)).
Figure 4(b) showed no growth inhibition zone at all tested
concentration of propolis; this demonstrates that propolis
extract does not affect the growth of C. violaceum CV026.
QS inhibitory activity was already reported for dis-
tinct propolis samples from the United States, being such
activities dependent on the geographic origin of propolis
[83]. The authors considered that pinocembrin present in
poplar propolis was a potential active compound on the
QS inhibitory activity. However, in South African propo-
lis, [84] reported that only caffeic acid had anti-quorum
sensing property, being the remaining compounds present
in propolis, including pinocembrin and their derivatives,
unable to inhibit the violacein production, and therefore
without anti-quorum sensing activity. Other studies showed
that an isoprenyl caffeate-rich fraction of manuka propolis
was particularly an active QS inhibitor [13]. These authors
found that 1 mg dry weight/disc or at least 0.450 mg/mL
of that fraction of manuka propolis completely inhibited
violacein production, concluding the authors that the pres-
ence of isoprenyl caffeate was very important on the activity
detected, because the activities found by other authors [85,
86] in distinct propolis samples were drastically inferior to
those found by them. In the present work, isocupressic acid
(8.1%), a diterpene, was the major compound of Moroccan
propolis, immediately followed by pinocembrin (7.4%). Both
compounds alone or along with other compounds present in
the sample may have been responsible for the activity found.
3.3.5. Influence of Propolis Extract on Virulence. The impact
of adaptation on virulence of S. aureus strains was evaluated
with theG.mellonellamodel. Adapted MRSA15 andMRSA16
strains submitted to subinhibitory propolis concentration
were injected in G. mellonella larvae, and their survival was
monitored (Figure 5). Differences in the ability of MRSA15
and MRSA16 to cause the death of the larvae were observed.
It was found that larvae injected with MRSA15 adapted
cells presented 100% of survival in comparison with 43%
of survival of insects injected with nonadapted cells (p <
0.001). MRSA15 was the less virulent strain in contrast to
MRSA16 that caused a mortality of 20% of larvae injected
with nonadapted cells by the end of the experiment; also
significant differences (p < 0.001) in mortality of insects
were observed between adapted and nonadapted cells. Larvae
injected with PBS achieved a 100% survival until the end of
the experiment.
The G. mellonella model has been used to evaluate the
virulence potential of several human pathogens, including S.
aureus and MRSA strains [60, 87]. This choice to use this
model was also based on the fact that propolis has practically
no toxic effect on the insect [88], although other studies
had demonstrated the opposite, particularly for Chinese and
Egyptian propolis extracts [89]. The results of the present
work show that sequential exposure of MRSA strains to
subinhibitory propolis concentration affected their virulence.
Suchdata evidence thatMoroccanpropoliswith diterpenes as
main group of secondary metabolites has capacity for com-
bating MRSA strains diminishing their virulence potential,
inhibiting the formation of biofilm.
The screening of different Moroccan propolis samples
regarding their antioxidant activities has revealed different
antioxidant activities; these differences can be attributed to
the compounds with antioxidant capacity in each propolis
sample. This finding also illustrates the diversity of propolis
and presents propolis as an important source of exogenous
antioxidant that can be highly involved in the ROS related
human diseases. On the other hand, we report in this work
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Figure 4: Anti-QS properties of propolis and catechin. (a) N-hexanoylhomoserine lactone (C6-HSL) at 0.12 𝜇g/mL was added to the culture
medium. (b) No addition of C6-HSL to the culture medium. In each well was added (A): ethanol 70%; (B): propolis at 0.24 mg/mL; (C):
propolis at 0.36 mg/mL; (D): propolis at 0.49 mg/mL; (E): propolis at 0.61mg/mL; (F): propolis at 0.73 mg/mL; (G): propolis at 0.98 mg/mL;
(H): propolis at 1.22 mg/mL. (B’): (+)-catechin at 0.24 mg/mL; (C’): (+)-catechin at 0.36 mg/mL; (D’): (+)-catechin at 0.49 mg/mL; (E’):
(+)-catechin at 0.61mg/mL; (F’): (+)-catechin at 0.73 mg/mL; (G’): (+)-catechin at 0.98 mg/mL; (H’): (+)-catechin at 1.22 mg/mL. This assay
was conducted in three independent triplicates (N=9).
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Figure 5: Kaplan–Meier survival curves for insects after injection with adapted cells (three passages at subinhibitory propolis concentration
(0.24mg/mL)) andnonadapted cells (three passages inBHIonly, control). Testwasdonewith sample 1. Data are themeanof three independent
experiments (n = 30). Larvae injected with PBS showed a 100 % over the experiment.
the efficiency of one of the most active propolis samples,
as antibacterial agent against Staphylococcus aureus strains.
Propolis did not induce the development of resistance to
antibiotics, inhibit the biofilm formation, possess an anti-
quorum sensing, and diminished the virulence of S. aureus
for all tested strains.
It is clearly concluded that propolis from Morocco can
be used in different field, as antioxidant source in order to
use it on the benefit of human health and well-being. Also,
being a natural product, it can be a brilliant candidate for
biomedical application to combat nosocomial disease and the
biofilm formation on medical device caused by S. aureus.
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